Paul van Slyke
Chief Tech/Sci/R&D Officer presso PHARMADRUG INC.
Profilo
Paul van Slyke is currently the Chief Scientific Officer at Pharmadrug, Inc. He previously held the same position at Vasomune Therapeutics, Inc. and Sairiyo Therapeutics, Inc. He obtained a doctorate degree from the University of Toronto.
Posizioni attive di Paul van Slyke
| Società | Posizione | Inizio |
|---|---|---|
| PHARMADRUG INC. | Chief Tech/Sci/R&D Officer | 13/05/2021 |
Precedenti posizioni note di Paul van Slyke
| Società | Posizione | Fine |
|---|---|---|
Sairiyo Therapeutics, Inc.
 Sairiyo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Pharmadrug, Inc., Sairiyo Therapeutics, Inc. is a Canadian company that manufactures and sells pharmaceutical products. Sairiyo Therapeutics was acquired by Pharmadrug, Inc. | Chief Tech/Sci/R&D Officer | - |
Vasomune Therapeutics, Inc.
 Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Vasomune Therapeutics, Inc. operates as an early stage biopharmaceutical company. It develops medicines to harness the body’s ability to defend against illness by modifying cellular response to disease. The company is headquartered in Toronto, Canada. | Chief Tech/Sci/R&D Officer | - |
Formazione di Paul van Slyke
| University of Toronto | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PHARMADRUG INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Sairiyo Therapeutics, Inc.
Sairiyo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Pharmadrug, Inc., Sairiyo Therapeutics, Inc. is a Canadian company that manufactures and sells pharmaceutical products. Sairiyo Therapeutics was acquired by Pharmadrug, Inc. | Health Technology |
Vasomune Therapeutics, Inc.
Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Vasomune Therapeutics, Inc. operates as an early stage biopharmaceutical company. It develops medicines to harness the body’s ability to defend against illness by modifying cellular response to disease. The company is headquartered in Toronto, Canada. | Health Technology |
- Borsa valori
- Insiders
- Paul van Slyke
